{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:35:02Z","timestamp":1760297702394},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4721,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1093\/annonc\/mdl348","type":"journal-article","created":{"date-parts":[[2006,10,28]],"date-time":"2006-10-28T01:17:17Z","timestamp":1161998237000},"page":"136-142","source":"Crossref","is-referenced-by-count":10,"title":["Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas\u2014results of a randomized comparison by the German Low-Grade Lymphoma Study Group"],"prefix":"10.1016","volume":"18","author":[{"given":"C.","family":"Nickenig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dreyling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hoster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-D.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"D\u00f6rken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Freund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tr\u00fcmper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Forstpointner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Unterhalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl348_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/11.suppl_1.S23","article-title":"Follicular lymphoma: have we made any progress?","volume":"11","author":"Horning","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.seminoncol.2003.10.006","article-title":"Future directions in radioimmunotherapy for B-cell lymphoma","volume":"30","author":"Horning","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bmt.1701101","article-title":"High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma","volume":"21","author":"Weaver","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.bmt.1702336","article-title":"Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)","volume":"25","author":"Voso","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0030","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdl348_bb0035","first-page":"62","volume":"16","author":"Rohatiner","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/11.suppl_1.S91","article-title":"The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)","volume":"11","author":"Schouten","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00277-002-0581-1","article-title":"Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab","volume":"82","author":"Herold","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdl348_bb0050","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl348_bb0055","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.160.160","article-title":"Rituximab added to IFN + CHVP improves the outcome of follicular lymphoma patients with a high tumor burden: first analysis of the GELA-GOELAMS FL- 2000 randomized trial in 359 patients","volume":"104","author":"Salles","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl348_bb0060","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl348_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.thj.6200061","article-title":"Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma","volume":"1","author":"Micallef","year":"2000","journal-title":"Hematol J"},{"key":"10.1093\/annonc\/mdl348_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/10428190009113381","article-title":"Characterization and outcome of \u2018hard to mobilize\u2019 lymphoma patients undergoing autologous stem cell transplantation","volume":"39","author":"Sugrue","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdl348_bb0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2141.1997.2743091.x","article-title":"Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system","volume":"98","author":"Drake","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdl348_bb0080","first-page":"836","article-title":"Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group","volume":"10","author":"Unterhalt","year":"1996","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdl348_bb0085","series-title":"Organisation Classification of Tumours: Tumours of the Hematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1093\/annonc\/mdl348_bb0090","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0095","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/cncr.22093","volume":"107","author":"Nickenig","year":"2006","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl348_bb0100","article-title":"The design and analysis of sequential clinical trials","author":"Whitehead","year":"1992","journal-title":"Ellis Horwood"},{"key":"10.1093\/annonc\/mdl348_bb0105","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1200\/JCO.2004.06.016","volume":"22","author":"Lenz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00252951","article-title":"Comparative in vitro toxicity of mitoxantrone and adriamycin in human granulocyte-macrophage progenitor cells","volume":"20","author":"Mergenthaler","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdl348_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10428190290006198","article-title":"Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+\/CD38+ and CD34+\/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells","volume":"43","author":"Chow","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdl348_bb0120","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","article-title":"Factors that influence collection and engraftment of autologous peripheral-blood stem cells","volume":"13","author":"Bensinger","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl348_bb0125","first-page":"311","article-title":"Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma","volume":"4","author":"Moskowitz","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdl348_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2141.2003.04107.x","article-title":"Mobilization of CD34+ cells in elderly patients (>\/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen","volume":"120","author":"Morris","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdl348_bb0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1703364","article-title":"Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma","volume":"29","author":"Pavone","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1701461","article-title":"Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system","volume":"22","author":"Clark","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2141.1997.1812998.x","article-title":"Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide","volume":"98","author":"McQuaker","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdl348_bb0150","first-page":"33","article-title":"Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV)","volume":"64","author":"O'Connell","year":"2001","journal-title":"Eur J Haematol Suppl"},{"key":"10.1093\/annonc\/mdl348_bb0155","first-page":"85","article-title":"DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma","volume":"16","author":"Olivieri","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0160","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/bjc.1993.460","article-title":"Effective mobilisation of peripheral blood progenitor cells with \u2018Dexa-BEAM\u2019 and G-CSF: timing of harvesting and composition of the leukapheresis product","volume":"68","author":"Dreger","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdl348_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1702531","article-title":"A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma","volume":"26","author":"Stiff","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.bmt.1704184","article-title":"Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?","volume":"32","author":"Jantunen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl348_bb0175","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","article-title":"Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group","volume":"104","author":"Lenz","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl348_bb0180","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2004-10-3920","article-title":"High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS","volume":"105","author":"Deconinck","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1093\/annonc\/mdl348_bb0185","first-page":"104","volume":"102","author":"Sebban","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl348_bb0190","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl348_bb0195","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","volume":"108","author":"Buske","year":"2006","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419375775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419375775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/1\/136\/795204\/mdl348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:21:54Z","timestamp":1624436514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419375775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0923753419375775"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl348","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}